Abstract
Previous chapters in this section have described the multiple aspects of headache-attributed burden and methods by which many of these may be quantified. This chapter addresses financial costs as an important component of headache-attributed burden. It explains some principal aspects of the methodology of health economic studies on headache and presents the findings of key studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Institute for Health Metrics and Evaluation. The global burden of disease: generating evidence, guiding policy. 2010. http://www.healthdata.org/gbd.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59.
Clarke CE, MacMillan L, Sondhi S, Wells NEJ. Economic and social impact of migraine. Quart J Med. 1996;89:77–84.
Rasmussen BK. Epidemiology and socio-economic impact of headache. Cephalalgia. 1999;19(Suppl 25):20–3.
Lanteri-Minet M. Economic burden and costs of chronic migraine. Curr Pain Headache Rep. 2014;18:385.
Solomon GD, Price KL. Burden of migraine. A review of its socioeconomic impact. PharmacoEconomics. 1997;11(Suppl 1):1–10.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56:S20–8.
Stewart WF, Lipton RB, Kolodner K, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41–52.
Steiner TJ. Lipton RB on behalf of Lifting The Burden: the Global Campaign against Headache. The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research. J Headache Pain. 2018;19:12.
Migraine in America. The hidden costs of migraine. 2016. https://migraine.com/infographic/the-hidden-cost-of-care.
Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19:703–43.
Payne KA, Varon SF, Kawatam AK, Yeomans K, Wilcox TK, Manack Adams A, et al. The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics. Cephalalgia. 2011;31:1116–30.
Mennini FS, Gitto L, Martelletti P. Improving care through health economics analyses: cost of illness and headache. J Headache Pain. 2008;9:199–206.
Akobundu E, Ju J, Blatt L, Daniel Mullins C. Cost-of-illness studies. A review of current methods. PharmacoEconomics. 2006;24:869–90.
Fishman P, Von Korff M, Lozano P, Hecht J. Chronic care costs in managed care. Health Aff. 1997;16:239–47.
Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49:368–74.
Mennini FS, Gitto L, Marcellusi A, Sakai F, Arakawa I. Economics of headache. In: Martelletti P, Steiner TJ, editors. Handbook of headache: practical management. Milan: Springer; 2011.
Sanderson JC, Devine EB, Lipton RB, Bloudek LM, Varon SF, Blumenfeld AM, et al. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013;84:1309–17.
Steiner TJ, Gururaj G, Andrée C, Katsarava Z, Ayzenberg I, Yu SY, et al. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain. 2014;15:3.
Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache. 2018;58:700–14.
Iigaya M, Sakai F, Kolodner KB, Lipton RB, Stewart WF. Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2003;43:343–52.
Lofland JH, Frick KD. Workplace absenteeism and aspects of access to health care for individuals with migraine headache. Headache. 2006;46:563–76.
Burton WN, Landy SH, Downs KE, Runken MC. The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc. 2009;84:436–45.
Holroyd KA, Stensland M, Lipchik GL, Hill KR, O’Donnell FS, Cordingley G. Psychosocial correlates and impact of chronic tension-type headaches. Headache. 2000;40:3–16.
Smith AP. Acute tension-type headaches are associated with impaired cognitive function and more negative mood. Front Neurol. 2016;7:42.
Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med. 1997;39:320–7.
Science Daily. 86 million workdays lost to migraine in the UK every year. 2018. https://www.sciencedaily.com/releases/2018/04/180427144727.htm.
Serrano D, Manack A, Reed ML, Buse DC, Varon SF, Lipton RB. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Value Health. 2013;16:31–8.
National Headache Foundation. https://headaches.org/resources/headache-diary-keeping-a-diary-can-help-your-doctor-help-you/. Accessed June 2018.
Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813–8.
Barron R, Carlsen J, Duff SB, Burk C. Estimating the cost of an emergency room visit for migraine headache. J Med Econ. 2003;6:43–53.
Cerbo R, Pesare M, Aurilia C, Rondelli V, Barbanti P. Socio-economic costs of migraine. J Headache Pain. 2001;2:S15–9.
Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers. J Occup Environ Med. 2004;46:398–412.
Stewart WF, Wood GC, Razzaghi H, Reed ML, Lipton RB. Work impact of migraine headaches. J Occup Environ Med. 2008;50:736–45.
The Eurolight project. 2012. http://www.eurolight-online.eu.
Jönsson B. General principles of disease-costing. In: Olesen J, Steiner T, Lipton R, editors. Reducing the burden of headache. Oxford: Oxford University Press; 2003. p. 211–7.
Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol. 2009;16:968–81.
Jones G. How often were you absent? A review of the use of self-reported absence data. J Appl Psychol. 1994;79:574–91.
Olesen J, Freund TF. European brain council: partnership to promote European and national brain research. Trends Neurosci. 2006;29:493–5.
Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B on behalf of the CDBE2010 study group and the European Brain Council. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155–62.
Stovner LJ, Andrée C. Impact of headache in Europe: a review for the Eurolight project. J Headache Pain. 2008;9:139–46.
Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011;51:1058–77.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mennini, F.S., Gitto, L. (2019). The Financial Costs of Headache. In: Steiner, T., Stovner, L. (eds) Societal Impact of Headache. Headache. Springer, Cham. https://doi.org/10.1007/978-3-030-24728-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-24728-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24726-3
Online ISBN: 978-3-030-24728-7
eBook Packages: MedicineMedicine (R0)